Why patients don't take part in cancer clinical trials: an overview of the literature (Q35145266)

6 August 2017

1 reference

title

Why patients don't take part in cancer clinical trials: an overview of the literature (English)

1 reference

6 August 2017

Cox K

1 reference

6 August 2017

McGarry J

series ordinal

1 reference

6 August 2017

language of work or name

English

0 references

publication date

1 June 2003

1 reference

European Journal of Cancer Care

6 August 2017

published in

1 reference

6 August 2017

1 reference

6 August 2017

1 reference

6 August 2017

page(s)

114-122

1 reference

Are randomized clinical trials good for us (in the short term)? Evidence for a "trial effect".

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2354.2003.00396.X

The Value of Clinical Trials from a Patient Perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2354.2003.00396.X

Small-cell lung cancer: patients included in clinical trials are not representative of the patient population as a whole.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2354.2003.00396.X

African Americans' views on research and the Tuskegee Syphilis Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2354.2003.00396.X

Reasons for accepting or declining to participate in randomized clinical trials for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2354.2003.00396.X

Challenges in palliative care research; recruitment, attrition and compliance: experience from a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2354.2003.00396.X

Patients' willingness to enter clinical trials: measuring the association with perceived benefit and preference for decision participation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2354.2003.00396.X

Ethical aspects of clinical trials: the attitudes of participants in two non-cancer trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2354.2003.00396.X

Evaluating minority recruitment into clinical studies: How good are the data?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2354.2003.00396.X

Clinical trial participation. Viewpoints from racial/ethnic groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2354.2003.00396.X

A guinea pig's view on prostate cancer screening trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2354.2003.00396.X

Recruitment of patients with lung cancer into a randomised clinical trial: experience at two centres. On behalf of the Big Lung Trial Steering Committee

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2354.2003.00396.X

Centralised treatment, entry to trials and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2354.2003.00396.X

Determinants of patient participation in clinical studies requiring informed consent: why patients enter a clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2354.2003.00396.X

10.1046/J.1365-2354.2003.00396.X

21 January 2018

Identifiers

DOI

1 reference

6 August 2017

1 reference